Epsiode 110: The HER-MES trial is a newly published study comparing the tolerability and efficacy of topiramate (Topamax) and erenumab (Aimovig). The results of this trial could impact prescribing practices and payor policies. Tune in this afternoon for this episode of Heads UP as Lindsay Weitzel, PhD, and Tim Smith, MD, discuss the important aspects of the HER-MES trial.
Follow the National Headache Foundation's podcast HeadWise, as host Lindsay Weitzel, PhD, has informative discussions with headache experts on the latest treatment, research, lifestyle recommendations, and personal stories about living with migraine disease and headache disorders. HeadWise can be found on Apple Podcasts, Spotify, Stitcher, Overcast, or wherever you get your podcasts.
Subscribe for more episodes just like this: / nationalheadachefounda...
====================================================
Visit our website:
headaches.org/
====================================================
Follow us on social media:
Facebook: / nationalheadachefounda...
Instagram: / nationalheadachefounda...
Twitter: / nhf
====================================================
Download our podcast:
Apple Podcast: podcasts.apple.com/us/podcast...
Spotify: open.spotify.com/show/6Ip8umh...
#podcast #migraine #headache #healthcare #medication #research